Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Research Paper from Dr. Lilge

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Sep 10, 2021 2:53pm

140 Views

Post# 33840834

RE:RE:RE:RE:New Research Paper from Dr. Lilge

That's what I'm hoping. As we treat more and more patients in 2022 the results should look better and better. The market can't ignore superior, efficacy, safety and convenience forever.

VentureGuy24 wrote: I didn't look at it in that perspective! Good point. Accelerated approvals is the dark horse.

So by 2023- we see dollars not pennies?

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages